Endocrine Today Current Issue

The following articles appeared in the print edition of Endocrine Today.

Table of Contents

• Compounded hormone therapies: unproven, untested — and popular
• Osteonecrosis of the jaw and bisphosphonate use: How big a risk?
• Do patients with osteoporosis need a thorough dental exam before starting bisphosphonate therapy?
• FDA proposes new drug information guidance
• Was the action by the FDA warranted — and is it enough?
• George Nicholas Papanicolaou — 1883-1962
• Ankle pain in the diabetic patient – Is it just a sprain? Patris Toney, DPM, MPH
• Is the diagnosis latent or patent? Ronald Tamler, MD, PhD, MBA
• Are you a diabetes consultant, counselor or coach? Mary M. Austin
• Cardiovascular update on TZDs Peter W.F. Wilson, MD
• MODY: an underdiagnosed and underappreciated condition
• Novel treatments seem promising for central precocious puberty Paul Saenger, MD, MACE
• Board reviews: A closer look at various certifications for graduating fellows Susan Peng, MD
• Autopsies in 1700s provided early evidence against the four humors
• The dead shall teach the living
• Thyroid nodule or parathyroid adenoma? Stephanie L. Lee, MD, PhD, ECNU
• Ouch! Richard O. Dolinar, MD
• ACCORD trial treatment arm halted
• Children with high BMI, waist circumference at risk for metabolic syndrome later
• Dietary restraint and bone health in adolescent runners
• Error reporting lacking in medical centers
• HT had no significant impact on MI risk in WHI replication trial
• Intervention therapy reduced CVD in patients with type 2 diabetes
• Metabolic syndrome during childhood led to type 2 diabetes later in life
• Metformin reversed weight gain from certain antipsychotic drugs
• Metabolic syndrome and the role of bariatric surgery Brant K. Oelschlager, MD; Ani J. Fleisig, MD
• Pediatric endocrinologist takes her work to island of Mauritius
• Sitagliptin for the treatment of type 2 diabetes James R. Taylor, PharmD, CDE